Enoxaparin sodium prevents intestinal microcirculatory dysfunction in endotoxemic rats

Critical Care

Volumn 16, Issue 2, 2012, Pages

  Yeh, Yu Chang ^a,b   Wang, Ming Jiuh ^a   Lin, Chih Peng ^a   Fan, Shou Zen ^a   Tsai, Jui Chang ^b   Sun, Wei Zen ^a   Ko, Wen Je ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM DISEASE; DRUG EFFECT; ENDOTOXEMIA; INTESTINE BLOOD FLOW; INTESTINE MICROCIRCULATORY DYSFUNCTION; LAPAROTOMY; MALE; MICROANGIOPATHY; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BLOOD FLOW VELOCITY; DRUG EFFECTS; HEMODYNAMICS; INTESTINE; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; VASCULARIZATION; WISTAR RAT;

ANIMALS; BLOOD FLOW VELOCITY; ENDOTOXEMIA; ENOXAPARIN; HEMODYNAMICS; INTESTINES; LIPOPOLYSACCHARIDES; MALE; MICROCIRCULATION; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC;

EID: 84859707921     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11303     Document Type: Article

References (35)

1. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker MM, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC, . Surviving Sepsis Campaign The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 2010, 38:367-374. 10.1097/CCM.0b013e3181cb0cdc, 20035219, Surviving Sepsis Campaign.
2. Winters BD, Eberlein M, Leung J, Needham DM, Pronovost PJ, Sevransky JE. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med 2010, 38:1276-1283.
3. Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med 2010, 38:S26-34.
4. Schouten M, Wiersinga WJ, Levi M, van der Poll T. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008, 83:536-545.
5. Lam C, Tyml K, Martin C, Sibbald W. Microvascular perfusion is impaired in a rat model of normotensive sepsis. J Clin Invest 1994, 94:2077-2083. 10.1172/JCI117562, 294647, 7962554.
6. Nimah M, Brilli RJ. Coagulation dysfunction in sepsis and multiple organ system failure. Crit Care Clin 2003, 19:441-458. 10.1016/S0749-0704(03)00008-3, 12848314.
7. Vincent JL, De Backer D. Microvascular dysfunction as a cause of organ dysfunction in severe sepsis. Crit Care 2005, 9:S9-12. 10.1186/cc3748, 3226162, 16168075.
8. Ince C. The microcirculation is the motor of sepsis. Crit Care 2005, 9:S13-19. 10.1186/cc3753, 3226164, 16168069.
9. Farquhar I, Martin CM, Lam C, Potter R, Ellis CG, Sibbald WJ. Decreased capillary density in vivo in bowel mucosa of rats with normotensive sepsis. J Surg Res 1996, 61:190-196. 10.1006/jsre.1996.0103, 8769965.
10. Overhaus M, Togel S, Pezzone MA, Bauer AJ. Mechanisms of polymicrobial sepsis-induced ileus. AmJ Physiol 2004, 287:G685-694.
11. Theuer CJ, Wilson MA, Steeb GD, Garrison RN. Microvascular vasoconstriction and mucosal hypoperfusion of the rat small intestine during bacteremia. Circ Shock 1993, 40:61-68.
12. Mythen MG, Purdy G, Mackie IJ, McNally T, Webb AR, Machin SJ. Postoperative multiple organ dysfunction syndrome associated with gut mucosal hypoperfusion, increased neutrophil degranulation and C1-esterase inhibitor depletion. Br J Anaesth 1993, 71:858-863. 10.1093/bja/71.6.858, 8280554.
13. Lendemans S, Peszko A, Oberbeck R, Schmitz D, Husain B, Burkhard M, Schade FU, Flohe S. Microcirculatory alterations of hepatic and mesenteric microcirculation in endotoxin tolerance. Shock 2008, 29:223-231.
14. Singer G, Stokes KY, Terao S, Granger DN. Sepsis-induced intestinal microvascular and inflammatory responses in obese mice. Shock 2009, 31:275-279. 10.1097/SHK.0b013e3181834ab3, 18665045.
15. Draijer M, Hondebrink E, van Leeuwen T, Steenbergen W. Review of laser speckle contrast techniques for visualizing tissue perfusion. Lasers Med Sci 2009, 24:639-651. 10.1007/s10103-008-0626-3, 2701498, 19050826.
16. Iba T, Takayama T. Enoxaparin attenuates endothelial damage with less bleeding compared with unfractionated heparin in endotoxemic rats. Shock 2009, 32:530-534. 10.1097/SHK.0b013e3181a2e279, 19295478.
17. Lehmann C, Meissner K, Knock A, Diedrich S, Pavlovic D, Grundling M, Usichenko T, Wendt M, Birnbaum J. Activated protein C improves intestinal microcirculation in experimental endotoxaemia in the rat. Crit Care 2006, 10:R157. 10.1186/cc5093, 1794461, 17101035.
18. Boas DA, Dunn AK. Laser speckle contrast imaging in biomedical optics. J Biomed Opt 2010, 15:011109. 10.1117/1.3285504, 2816990, 20210435.
19. De Backer D, Hollenberg S, Boerma C, Goedhart P, Buchele G, Ospina-Tascon G, Dobbe I, Ince C. How to evaluate the microcirculation: report of a round table conference. Crit Care 2007, 11:R101. 10.1186/cc6118, 2556744, 17845716.
20. Trzeciak S, McCoy JV, Phillip Dellinger R, Arnold RC, Rizzuto M, Abate NL, Shapiro NI, Parrillo JE, Hollenberg SM. Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med 2008, 34:2210-2217. 10.1007/s00134-008-1193-6, 2821162, 18594793.
21. Ince C, Sinaasappel M. Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 1999, 27:1369-1377. 10.1097/00003246-199907000-00031, 10446833.
22. Marx G, Vangerow B, Burczyk C, Gratz KF, Maassen N, Cobas Meyer M, Leuwer M, Kuse E, Rueckholdt H. Evaluation of noninvasive determinants for capillary leakage syndrome in septic shock patients. Intensive Care Med 2000, 26:1252-1258. 10.1007/s001340000601, 11089750.
23. Hersch M, Scott JA, Izbicki G, McCormack D, Cepinkas G, Ostermann M, Sibbald WJ. Differential inducible nitric oxide synthase activity in circulating neutrophils vs. mononuclears of septic shock patients. Intensive Care Med 2005, 31:1132-1135. 10.1007/s00134-005-2680-7, 15959762.
24. Baumgarten G, Knuefermann P, Schuhmacher G, Vervolgyi V, von Rappard J, Dreiner U, Fink K, Djoufack C, Hoeft A, Grohe C, Knowlton AA, Meyer R. Toll-like receptor 4, nitric oxide, and myocardial depression in endotoxemia. Shock 2006, 25:43-49.
25. Iba T, Miyasho T. Danaparoid sodium attenuates the increase in inflammatory cytokines and preserves organ function in endotoxemic rats. Crit Care 2008, 12:R86. 10.1186/cc6943, 2575560, 18601748.
26. Hagiwara S, Iwasaka H, Hidaka S, Hishiyama S, Noguchi T. Danaparoid sodium inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats. Crit Care 2008, 12:R43. 10.1186/cc6851, 2447588, 18380908.
27. Li LF, Huang CC, Lin HC, Tsai YH, Quinn DA, Liao SK. Unfractionated heparin and enoxaparin reduce high-stretch ventilation augmented lung injury: a prospective, controlled animal experiment. Crit Care 2009, 13:R108. 10.1186/cc7949, 2750150, 19580651.
28. Vincent JL. Microvascular endothelial dysfunction: a renewed appreciation of sepsis pathophysiology. Crit Care 2001, 5:S1-5. 10.1186/cc1332, 11933880.
29. Bateman RM, Sharpe MD, Ellis CG. Bench-to-bedside review: microvascular dysfunction in sepsis--hemodynamics, oxygen transport, and nitric oxide. Crit Care 2003, 7:359-373. 10.1186/cc2353, 270719, 12974969.
30. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003, 101:3765-3777. 10.1182/blood-2002-06-1887, 12543869.
31. Trzeciak S, Cinel I, Phillip Dellinger R, Shapiro NI, Arnold RC, Parrillo JE, Hollenberg SM. Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med 2008, 15:399-413. 10.1111/j.1553-2712.2008.00109.x, 2727641, 18439194.
32. De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002, 166:98-104. 10.1164/rccm.200109-016OC, 12091178.
33. Hoffmann JN, Vollmar B, Inthorn D, Schildberg FW, Menger MD. A chronic model for intravital microscopic study of microcirculatory disorders and leukocyte/endothelial cell interaction during normotensive endotoxemia. Shock 1999, 12:355-364. 10.1097/00024382-199911000-00005, 10565610.
34. Hoffman JN, Fertmann JM, Vollmar B, Laschke MW, Jauch KW, Menger MD. Immunoglobulin M-enriched human intravenous immunoglobulins reduce leukocyte-endothelial cell interactions and attenuate microvascular perfusion failure in normotensive endotoxemia. Shock 2008, 29:133-139.
35. Hoffmann JN, Vollmar B, Inthorn D, Schildberg FW, Menger MD. The thrombin antagonist hirudin fails to inhibit endotoxin-induced leukocyte/endothelial cell interaction and microvascular perfusion failure. Shock 2000, 14:528-534. 10.1097/00024382-200014050-00006, 11092685.